Genetic Technologies Ltd. ADR (GENE) News

Genetic Technologies Ltd. ADR (GENE): $1.67

0.02 (+1.21%)

POWR Rating

Component Grades








Filter GENE News Items

GENE News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

GENE News Highlights

  • For GENE, its 30 day story count is now at 2.
  • Over the past 2 days, the trend for GENE's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • DEC, ASX and GOLD are the most mentioned tickers in articles about GENE.

Latest GENE News From Around the Web

Below are the latest news stories about GENETIC TECHNOLOGIES LTD that investors may wish to consider to help them evaluate GENE as an investment opportunity.

GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness

MELBOURNE, Australia, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies (GTG) is proud to provide details of a series of recent transformative initiatives. Our commitment to advancing early detection of serious diseases through a revolutionary non-invasive saliva test has been recently showcased on several national Australian media channels. These segments highlight geneType's potential to shape the future of proactive health management. Precision Medicine Takes Flight at Gold Coast Private

Yahoo | December 14, 2023

Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change

MELBOURNE, Australia, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, announced today its plans to effect: (i) a share consolidation of its ordinary shares (the “Shares”) of one (1) for one hundred (100) existing Shares (the “Local Consolidation”) and (ii) a change of ratio in the Company’s American Depositary Share (“ADS”) program, comprising a change in th

Yahoo | December 12, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to start of the trading week with a look at the biggest pre-market stock movers worth watching on Monday morning!

William White on InvestorPlace | December 4, 2023

Here's Why Shareholders May Want To Be Cautious With Increasing Genetic Technologies Limited's (ASX:GTG) CEO Pay Packet

Key Insights Genetic Technologies to hold its Annual General Meeting on 21st of November Total pay for CEO Simon...

Yahoo | November 15, 2023

Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial

MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, is pleased to provide an update on the company activities for the quarter ending 30 September 2023. Highlights: Partnership signed with the Gold Coast Private Hospital (a member of Healthscope), to establish a Precision Medicine Clinic at the hospital.GeneType Multi-Test

Yahoo | October 30, 2023

GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment

MELBOURNE, Australia, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the publication of a peer-reviewed research paper validating geneType’s Pancreatic Cancer risk assessment test. Highlights: Pancreatic cancer has a very high mortality rate, approximately 76%1 of those diagnosed will die within 1 year. The five-year survival rate is

Yahoo | October 18, 2023

Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / October 6, 2023 / RedChip Companies will air interviews with Knightscope, Inc. (NASDAQ:KSCP), Soligenix, Inc. (Nasdaq:SNGX), and Genetic Technologies Limited (ASX:GTG)(NASDAQ:GENE) on The RedChip Small Stocks Big Money Show®, ...

Yahoo | October 6, 2023

Genetic Technologies building pathway to profitability

Genetic Technologies Ltd (ASX:GTG; NASDAQ:GENE) CEO Simon Morriss tells Proactive the focus over the next 18 years is putting the pathway in place to see the business on track to profitability. GTG...

Yahoo | September 27, 2023

GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network

GeneType and Gold Coast Hospital Simon Morriss - Genetic Technologies Ltd CEO and Michelle Ferrari Cestari - Gold Coast Hospital Research Manager GTG CEO, Simon Morriss, is pleased to announce collaboration with Gold Coast Hospital Simon Morriss, Genetic Technologies CEO's Statement MELBOURNE, Australia, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) – a global leader in genomics-based tests in health, wellness and serious disease is pl

Yahoo | September 27, 2023

Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

RedChip Companies will air interviews with Aridis Pharmaceuticals, Inc. (OTC:ARDS), Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE), and American Resources Corporation (Nasdaq:AREC) on The RedChip Money Report®, a sponsored program on Bloomberg TV, this Saturday, September 16, at 7 p.m. Eastern Time (ET).

Yahoo | September 15, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!